VOLEMIC AND HEMODYNAMIC STATUS OF PATIENTS WITH COMORBIDITY OF CORONARY HEART DISEASE AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE BEFORE AND AFTER MYOCARDIAL REVASCULARIZATION
https://doi.org/10.36604/1998-5029-2019-74-8-15
Abstract
About the Authors
B. I. GeltzerRussian Federation
MD, PhD, D.Sc. (Med.), Professor, Corresponding member of RAS, Director of the Department of Clinical Medicine
Building 25, Primorsky Krai, 690920, Russian Federation
E. A. Sergeyev
Russian Federation
MD, Anesthesiologist-resuscitator of the FEFU Medical Center, Postgraduate student
Building 25, Primorsky Krai, 690920, Russian Federation
V. Yu. Rublev
Russian Federation
MD, Cardiovascular surgeon, Postgraduate student
Building 25, Primorsky Krai, 690920, Russian Federation
E. V. Sergeeva
Russian Federation
MD, Assistant of the Institute of Pediatrics
2 Ostryakova Ave., Vladivostok, 690002, Russian Federation
V. Yu. Velichkin
Russian Federation
MD, Anesthesiologist-resuscitator
Building 25, Primorsky Krai, 690920, Russian Federation
References
1. Akhmedova E.B., Mardanov B.U., Mamedov M.N. Influence of somatic comorbidity on the course of coronary heart disease. Rossiyskiy kardiologicheskiy zhurnal 2017;22(9):55–59 (in Russian). doi: 10.15829/1560-4071-2017-9-55-59
2. Вarbarash O.L., Zhidkova I.I., Shibanova I.A., Ivanov S.V., Sumin A.N., Samorodskaya I.V., Barbarash L.S. The impact of comorbidities and age on the nosocomial outcomes of patients undergoing coronary artery bypass grafting. Kardiovaskulyarnaya terapiya i profilaktika 2019;18(2):58–64 (in Russian). doi: 10.15829/1728-8800-2019-2-58-64
3. Bober V.V., Domnin S.E., Pichugin V.V. Protection of lungs in the course of surgeries with artificial blood circulation. Meditsinskiy al'manakh 2017; 3(48): 123–127 (in Russian).
4. Bokeria O.L., Biniashvili M.B. Sudden cardiac death and coronary heart disease. Annaly aritmologii 2013;10(2): 69–79 (in Russian).
5. Boytsov S.A., Samorodskaya I.V., Nikulina N.N., Yakushin S.S., Andreev E.M., Zaratyants O.V., Barbarash O.L. Comparative analysis of mortality from acute forms of ischemic heart disease during a 15-year period in the Russian Federation and the United States and the factors influencing its formation. Terapevticheskiy arkhiv 2017; 89(9):53–59 (in Russian). doi: 10.17116/terarkh201789953-59
6. Geltser B.I., Kurpatov I.G., Kotelnikov V.N., Zayats Yu.V. Chronic obstructive pulmonary disease and cerebrovascular diseases: functional and clinical aspect of comorbidity. Terapevticheskiy arkhiv 2018; 19(3):81–88 (in Russian). doi: 10.26442/terarkh201890381-88
7. Kirov M.Y., Lenkin A.I., Kuzkov V.V. Use of transpulmonary thermodilution-based volumetric monitoring during cardiosurgical interventions. Obshchaya reanimatologiya 2005;1(6):70–79 (in Russian). doi: 10.15360/1813-9779-2005-6-70-79
8. Kozlov I.A., Romanov A.A. Respiratory biomechanics, intrapulmonary water, and pulmonary oxygenizing function during uncomplicated operations under extracorporeal circulation. Obshchaya reanimatologiya 2007;3(3):17–22 (in Russian). doi: 10.15360/1813-9779-2007-3-17
9. Kuz'kov V.V., Suborov E.V., Fot E.V., Rodionova L.N., Sokolova M.M., Lebedinskiy K.M., Kirov M.Ju. Postoperative respiratory complications and acute respiratory distress syndrome - better prevent then treat! Anesteziologiya i reanimatologiya 2016;61(6):461–468 (in Russian). doi: 10.18821/0201-7563-2016-6-461-468
10. Campo G., Pavasini R., Malagù M., Mascetti S., Biscaglia S., Ceconi C., Papi A., Contoli M. Chronic obstructive pulmonary disease and ischemic heart disease comorbidity: overview of mechanisms and clinical management. Cardiovasc. Drugs Ther. 2015; 29(2):147–157. doi: 10.1007/s10557-014-6569-y
11. Didenko D., Rasputina L., Mostovoy Y., Cherepii N. Comorbidity in patients with IHD - the prevalence of COPD. Eur. Respir. J. 2016;48(Suppl.60):PA1119. doi: 10.1183/13993003.congress-2016.PA1119
12. Grippi M.A. Pulmonary pathophysiology. Philadelpia: JB Lippincott Company; 1996.
13. Hilty M.P., Franzen D.P., Wyss C., Biaggi P., Maggiorini M. Validation of transpulmonary thermodilution variables in hemodynamically stable patients with heart diseases. Ann. Intensive Care 2017;7(1):86. doi: 10.1186/s13613-017-0307-0
14. Jozwiak M., Teboul J.L., Monnet X. Extravascular lung water in critical care: recent advances and clinical applications. Ann. Intensive Care 2015;5(1):38. doi: 10.1186/s13613-015-0081-9
15. Kurniawan E., Ding F. H., Zhang Q., Yang Z. K., Hu J., Shen W. F., Zhang R. Y. Predictive value of SYNTAX score II for clinical outcomes in octogenarian undergoing percutaneous coronary intervention. J. Geriatr. Cardiol. 2016;13
Review
For citations:
Geltzer B.I., Sergeyev E.A., Rublev V.Yu., Sergeeva E.V., Velichkin V.Yu. VOLEMIC AND HEMODYNAMIC STATUS OF PATIENTS WITH COMORBIDITY OF CORONARY HEART DISEASE AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE BEFORE AND AFTER MYOCARDIAL REVASCULARIZATION. Bulletin Physiology and Pathology of Respiration. 2019;(74):8-15. (In Russ.) https://doi.org/10.36604/1998-5029-2019-74-8-15